Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Orthop Res ; 24(3): 501-7, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16453344

ABSTRACT

The objective of this study was to investigate the potential application of cell-seeded biomaterials for revision arthroplasty and the reconstruction of major joints using the impaction grafting technique. Using morselized cancellous bone graft as a porous scaffold, MG63 cells were seeded on the scaffold and impacted into an acetabulum cup model using a mechanical device constructed from data obtained during impaction grafting by an orthopedic surgeon. Immediately after impaction, cells were trypsinized from the scaffold and processed for cell survival rates using the double-stranded DNA PicoGreen assay. Significant reductions in viable cells were observed between the fifth impact and both the first and second impacts (p < 0.01 and p < 0.05, respectively). Cell survival rate was 21.5% after five impacts. The biological performance of cell-seeded biomaterials may be enhanced by these surviving cells. Compared to allograft bone that is not osteogenic, a cell-seeded biomaterial might also be a suitable substitute for allograft bone for major joint reconstruction at revision arthroplasty.


Subject(s)
Arthroplasty, Replacement, Hip/instrumentation , Biocompatible Materials , Bone Transplantation , Osteocytes/transplantation , Tissue Engineering/methods , Animals , Arthroplasty, Replacement, Hip/methods , Cattle , Cell Adhesion , Cell Line, Tumor , Cell Survival , DNA/analysis , Microscopy, Electron, Scanning , Osteocytes/ultrastructure , Stress, Mechanical
2.
J Orthop Res ; 23(3): 625-31, 2005 May.
Article in English | MEDLINE | ID: mdl-15885484

ABSTRACT

Although the mechanisms of osteoinduction by bone morphogenic proteins (BMPs) are increasingly understood, the most appropriate time to administer BMPs exogenously is yet to be clarified. The purpose of this study was to investigate when BMP may be administered to a fracture arena to maximise the enhancement of healing. Forty mice with externally fixed left femoral fractures were randomised into four groups: Group I, the control group was given a placebo of 30 microl saline at day 0; Groups II, III and IV were given 30 microl saline plus 2.5 microg rhBMP-2, at post-operative days 0, 4 or 8, respectively. Sequential radiographs were taken at days 0, 8, 16. On day 22 the mice were sacrificed and both femora were harvested for biomechanical assessment in 3-point bending and histological evaluation. Radiographic analysis indicated that healing of fractures in Groups II and III was significantly greater (p < 0.05) than those in Groups I and IV, at both 16 and 22 days post-fracture. The highest median bone mineral content at the fracture site was evidenced in Group III and II. Furthermore, Group III also had the highest relative ultimate load values, followed by Groups II, IV and I. Greater percentage peak loads were observed between Group I and both Groups II and III (p < 0.05). Histological examination confirmed that at 22 days post-fracture, only fractures in Groups II and III had united with woven bone, and Groups I and IV still had considerable amounts of fibrous tissue and cartilage at the fracture gap. Data presented herein indicates that there is a time after fracture when rhBMP administration is most effective, and this may be at the time of surgery as well as in the early fracture healing phases.


Subject(s)
Bone Morphogenetic Proteins/therapeutic use , Femoral Fractures/drug therapy , Transforming Growth Factor beta/therapeutic use , Animals , Biomechanical Phenomena , Bone Morphogenetic Protein 2 , Femoral Fractures/physiopathology , Humans , Male , Mice , Osteogenesis/drug effects , Recombinant Proteins/therapeutic use , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...